Autolus Therapeutics plc

AUTL·NasdaqGS·Healthcare
Compare
1.7400−0.0700 (−3.87%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours1.8000+0.0600 (+3.45%)Oct 12, 5:57 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.8100
Open1.8000
Day range1.74001.8000
52-week range1.17502.5800
Off day high−3.33%
Off 52-week high−32.56%
Volume1.05M
Avg. volume (3M)2.09M
Market cap463.12M
EPS (TTM)-1.06
Forward P/E-2.78
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.14
Shares outstanding266.16M
Short interest4.87% of float
Earnings dateAug 11, 2026
Analyst target8.7250
Profit margin−238.65%

Against its peers

Compare in full ›
AUTL ALLO CABA FATE PGEN RNAC
Market cap 463.12M 483.69M 303.49M 255.22M 2.74B 211.48M
P/E (TTM) — — — — — —
Forward P/E -2.8 -2.3 -1.5 -2.2 -34.8 -1.8
Price/book 6.2 1.1 1.4 1.6 62.8 -1.7
Dividend yield — — — — — —
1-year change +7.41% +10.24% −22.49% +56.83% +143.30% −25.70%
Today −3.87% −4.11% −7.25% −2.29% −1.92% −0.92%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Autolus Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Allogene Therapeutics, Inc.ALLO · Biotechnology 483.69M 1.4000 −4.11%
Cabaletta Bio, Inc.CABA · Biotechnology 303.49M 1.7900 −7.25%
Fate Therapeutics, Inc.FATE · Biotechnology 255.22M 2.1300 −2.29%
Precigen, Inc.PGEN · Biotechnology 2.74B 7.66 −1.92%
Cartesian Therapeutics, Inc.RNAC · Biotechnology 211.48M 6.99 −0.92%
Cullinan Therapeutics, Inc.CGEM · Biotechnology 918.80M 14.95 −3.73%
Lyell Immunopharma, Inc.LYEL · Biotechnology 202.66M 8.27 −5.05%
Atara Biotherapeutics, Inc.ATRA · Biotechnology 94.15M 9.38 −1.05%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Entera Bio Ltd.ENTX · Jerusalem, Israel 460.66M 2.6500 −0.38%
Assembly Biosciences, Inc.ASMB · South San Francisco, CA 463.61M 22.77 −3.23%
Rezolute, Inc.RZLT · Redwood City, CA 471.04M 4.8700 0.00%
Ovid Therapeutics Inc.OVID · New York, NY 470.67M 2.4100 −2.03%
YD Bio LtdYDES · Taipei, Taiwan 448.36M 6.33 −5.94%
MapLight Therapeutics, Inc.MPLT · Redwood City, CA 477.95M 8.60 −2.60%
AgomAb Therapeutics NVAGMB · Antwerp, Belgium 447.66M 9.09 +0.11%
Allogene Therapeutics, Inc.ALLO · South San Francisco, CA 483.69M 1.4000 −4.11%

Healthcare companies of a similar market value (467.12M).

Company Mkt cap Price Today
Entera Bio Ltd.ENTX · Biotechnology 460.66M 2.6500 −0.38%
BrainsWay Ltd.BWAY · Medical Devices 461.30M 11.46 −2.63%
Assembly Biosciences, Inc.ASMB · Biotechnology 463.61M 22.77 −3.23%
Alpha Teknova, Inc.TKNO · Drug Manufacturers - Specialty & Generic 467.09M 8.70 −1.58%
Evolent Health, Inc.EVH · Health Information Services 480.50M 4.2500 +5.20%
Rezolute, Inc.RZLT · Biotechnology 471.04M 4.8700 0.00%
Ovid Therapeutics Inc.OVID · Biotechnology 470.67M 2.4100 −2.03%
Kamada Ltd.KMDA · Drug Manufacturers - Specialty & Generic 452.45M 7.84 −2.97%

Also based in London, United Kingdom, then elsewhere in United Kingdom.

Company Mkt cap Price Today
HSBC Holdings plcHSBC · London, United KingdomOdds 322.57B 94.32 +1.44%
Shell plcSHEL · London, United Kingdom 289.10B 101.59 +1.41%
Rio Tinto GroupRIO · London, United Kingdom 153.37B 94.30 −0.51%
Unilever PLCUL · London, United Kingdom 135.57B 62.95 +1.11%
British American Tobacco p.l.c.BTI · London, United Kingdom 119.64B 55.62 +0.22%
BP p.l.c.BP · London, United KingdomOdds 120.36B 46.73 +1.04%
GSK plcGSK · London, United Kingdom 94.00B 46.92 +0.90%
Lloyds Banking Group plcLYG · London, United Kingdom 78.26B 5.46 +0.92%

Companies that serve the same markets: life sciences.

Company Mkt cap Price Today
Novavax, Inc.NVAX · life sciences 2.09B 12.66 −0.71%
Nanobiotix S.A.NBTX · life sciences 1.19B 23.40 −1.18%
Replimune Group, Inc.REPL · life sciences 1.23B 13.07 −2.61%
Nektar TherapeuticsNKTR · life sciences 1.36B 39.84 −3.23%
Kailera Therapeutics, Inc.KLRA · life sciences 1.47B 11.33 −2.41%
Septerna, Inc.SEPN · life sciences 1.75B 37.56 −2.11%
Structure Therapeutics Inc.GPCR · life sciences 1.71B 23.91 −6.38%
Biohaven Ltd.BHVN · life sciences 1.78B 11.81 −2.24%

The stocks whose daily moves over the past year went most closely with Autolus Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Vir Biotechnology, Inc.VIR · Correlation 0.41 1.91B 11.30 −3.42%
Recursion Pharmaceuticals, Inc.RXRX · Correlation 0.40 2.15B 4.0100 −8.03%
Bicycle Therapeutics plcBCYC · Correlation 0.37 265.97M 3.8000 −2.31%
Allogene Therapeutics, Inc.ALLO · Correlation 0.35 483.69M 1.4000 −4.11%
Cartesian Therapeutics, Inc.RNAC · Correlation 0.33 211.48M 6.99 −0.92%
Arvinas, Inc.ARVN · Correlation 0.32 480.68M 7.45 −2.49%
MeiraGTx Holdings plcMGTX · Correlation 0.32 996.93M 10.38 −2.90%
Fate Therapeutics, Inc.FATE · Correlation 0.31 255.22M 2.1300 −2.29%

What visitors to Autolus Therapeutics's page also look at.

Company Mkt cap Price Today
Allogene Therapeutics, Inc.ALLO 483.69M 1.4000 −4.11%
MeiraGTx Holdings plcMGTX 996.93M 10.38 −2.90%
Bicycle Therapeutics plcBCYC 265.97M 3.8000 −2.31%
Cabaletta Bio, Inc.CABA 303.49M 1.7900 −7.25%
CytomX Therapeutics, Inc.CTMX 527.32M 2.4200 −5.84%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All AUTL news ›
markets.businessinsider.com·Positive

Autolus Therapeutics management to meet virtually with William Blair

Virtual Meeting to be held on September 24 hosted by William Blair. Published first on TheFly – the ultimate source for real-time, market-movin... Autolus Therapeutics management to meet virtually with William Blair Virtual Meeting to be…

markets.businessinsider.com·Positive

Autolus Therapeutics (AUTL) Receives a Buy from Wells Fargo

In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus Therapeutics, with a price target of $5.00. The company’... In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus…

markets.businessinsider.com·Positive

H.C. Wainwright Keeps Their Buy Rating on Autolus Therapeutics (AUTL)

In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Autolus Therapeutics, with a price target of $10.00. According to TipRanks, Bodnar is a 4-star analyst with an average return of 4.1% and a 37.75%…

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Mentioned with

Acrivon Therapeutics2HC Wainwright2Moonlake Immunotherapeutics2Wall Street Zen2Abu Dhabi Future Health1Amondys1Apitoria Pharma Private Limited1Aucatzyl1

People in the coverage

Danessa Lincoln2H.c. Wainwright2HC Wainwright2Kim Johansen2Marketbeat2Michael Walen2

Themes

Healthcare3Conference1Events1HC Wainwright1Health1Investor1New York1Politics1

Most coverage from

  1. markets.businessinsider.com3

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.